drugset / Trial / NCT00273442

Assessing Cosopt Switch Patients

NCT00273442

Phase 4 Completed 60 enrolled Pharmaceutical Research Network
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess the safety and efficacy of a cohort of patients switched to the dorzolamide/timolol maleate fixed combination because they are insufficiently controlled on latanoprost monotherapy.

Timeline

Start
2005-11
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dorzolamide Small molecule
Subject Timolol Other / unclassified